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Prion proteins were initially associated with diseases such as Creutzfeldt Jakob and
transmissible spongiform encephalopathies. However, deeper research revealed them
as versatile tools, exploited by the cells to execute fascinating functions, acting as
epigenetic elements or building membrane free compartments in eukaryotes. One of the
most intriguing properties of prion proteins is their ability to propagate a conformational
assembly, even across species. In this context, it has been observed that bacterial
amyloids can trigger the formation of protein aggregates by interacting with host proteins.
As our life is closely linked to bacteria, either through a parasitic or symbiotic relationship,
prion-like proteins produced by bacterial cells might play a role in this association.
Bioinformatics is helping us to understand the factors that determine conformational
conversion and infectivity in prion-like proteins. We have used PrionScan to detect prion
domains in 839 different bacteria proteomes, detecting 2200 putative prions in these
organisms. We studied this set of proteins in order to try to understand their functional
role and structural properties. Our results suggest that these bacterial polypeptides are
associated to peripheral rearrangement, macromolecular assembly, cell adaptability, and
invasion. Overall, these data could reveal new threats and therapeutic targets associated
to infectious diseases.
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INTRODUCTION
An increasing number of human diseases are being associated with amyloid forming proteins.
Despite these polypeptides are diverse in function, sequence and origin, all share the propensity
to form β-sheet aggregates (Karran et al., 2011). Amyloid fibril forming proteins appear to be
highly conserved and have been detected in all kingdoms of life, suggesting that, despite they
are usually thought to be involved in pathogenic processes, they might indeed provide selective
advantages (Sanchez de Groot et al., 2012, 2015; Espinosa Angarica et al., 2013; Malinovska et al.,
2013). In fact, cells exploit the formation of amyloid fibrils for diverse purposes (Coustou et al.,
1997; Iconomidou et al., 2000; Podrabsky et al., 2001; Chapman et al., 2002; Graether et al., 2003;
Fowler et al., 2006; Maji et al., 2009), from structure scaffolding, such as the melanin at the skin, to
heritable information transmission, such as the yeast prions (Chien and Weissman, 2001; Shorter
and Lindquist, 2005; Liebman and Chernoff, 2012; Staniforth and Tuite, 2012). Because amyloid
fibers and their unstable intermediates can be highly cytotoxic (e.g., by disrupting the membrane
integrity), the assembly of functional amyloids is a process tightly regulated by the cell, which
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involves the assistance of chaperones and a spatiotemporal
control (Blanco et al., 2012; Gsponer and Babu, 2012; Evans et al.,
2015; Taylor and Matthews, 2015).
Among amyloids, prions are a singular subset of proteins
able to change from one conformational state to another, often
an amyloid aggregate, and transmit it to other homologous
polypeptide sequences. Importantly, recent results suggest that
amyloid proteins involved in Alzheimer’s and Parkinson’s
diseases could be infectious and act as prion-like proteins
in the brain (Chiti and Dobson, 2006; Stöhr et al., 2012).
With the exception of the mammalian prion protein (PrP),
prion-like proteins constitute a subset of aggregation-prone
proteins with special sequential composition. Whereas, classical
amyloid proteins contain specific regions rich in hydrophobic
residues that lead the protein self-assembly, prion-like proteins
exhibit domains that are commonly enriched in asparagine and
glutamine (Q/N) (Dorsman et al., 2002; Fändrich and Dobson,
2002; Halfmann et al., 2011) but also in glycine, serine and
tyrosine residues (Kato et al., 2012). This pattern has been found
in human proteins associated to neurodegenerative diseases, such
as FUS (dementia) or TDP43 (amyotrophic lateral sclerosis;
Kato et al., 2012). This special residue content results in low
complexity sequences displaying disordered structures, a crucial
property that ensures conformational flexibility, permits self-
assembly without a requirement for conformational unfolding
and allows conversion between species (Tompa and Fuxreiter,
2008; Fuxreiter, 2012; Fuxreiter and Tompa, 2012; Malinovska
et al., 2013). In fact, one of the main evolutionary strategies
to control protein aggregation is to ensure a stable globular
structure preventing, in this way, the exposition of aggregation
prone stretches (Lim and Sauer, 1991; de Groot and Ventura,
2005; Ventura, 2005; Monsellier et al., 2007). However, a
polypeptide sequence requires more than just low complexity to
behave as a prion (Espinosa Angarica et al., 2013; Malinovska
et al., 2013). Hence, it has been found that the propagation
of amyloid aggregation depends on characteristics such as the
degree of over/under representation of specific residues and the
length of the considered low complexity region (Ross et al., 2004,
2005; Toombs et al., 2010).
The scientific community is getting closer to elucidate the
characteristics that differentiate prion and non-prion amyloid
proteins (Kushnirov et al., 2007; Newby and Lindquist, 2013;
Sabate et al., 2015). In this way, the knowledge acquired in the
last 5 years has allowed the design of prediction approaches to
identify putative prion proteins. The first predictive algorithms
were based on the properties of the primary sequence responsible
for the formation of the classical amyloid aggregates (e.g.,
high hydrophobicity and intrinsic β-sheet propensity). However,
they failed to detect Q/N-rich stretches since these are polar
residues that do not fulfill the typical requirements associated
with classical β-sheet-amyloid aggregation (Pawar et al., 2005).
Then, the algorithms focused on localizing Q/N rich segments
in the primary sequence (Michelitsch and Weissman, 2000;
Harrison and Gerstein, 2003), without paying much attention
to the contribution of the rest of residues (Ross et al., 2005),
being unable to score the proteins in terms of their relative
prionogenicity. A big improvement was achieved by combining
computational approaches with the experimental validation
of new proteins displaying in vitro prionic properties. This
strategy enlarged the set of prionic sequences and permitted the
refinement of the available theoretical models. Alberti and co-
workers employed a hiddenMarkovmodel (HMM), based on the
four bona fide yeast prions identified to that moment, obtaining
200 yeast protein candidates carrying putative prion domains
(PrDs; Alberti et al., 2009). The in vivo and in vitro analysis
of the top 100 candidates rendered 29 proteins that proved
heritable switch and significant in vivo amyloid formation.
We have recently exploited this experimentally curated dataset
to develop a probabilistic model of PrDs able to discover
prionogenic proteins in complete proteomes (Espinosa Angarica
et al., 2013). We have implemented this model in a web-
based algorithm called PrionScan able to handle with large
sequence databases and predict prion-like sequence stretches
in the proteomes annotated in UniprotKB (Espinosa Angarica
et al., 2014). In a previous work, we employed this predictor
to analyze all the proteomes reported until that moment (1536
organisms; Espinosa Angarica et al., 2014). We discovered 20540
new putative prions present in 10 different taxonomic divisions,
supporting prions universality. We also observed that in most
cases the ratio of proteins with prion-forming domains is less
than 1% of the whole proteome. Thus, in Archaea and Viruses
the number is less than 10 per proteome, while in Bacteria,
Fungi, Plantae, and Animalia the range is from few tens to
few hundreds, depending on the organisms. Interestingly, we
observed that, in different organisms, the predicted PrDs are
associated with different cellular components and biological
processes supporting prionic properties being employed for
diverse biological purposes.
Bacteria are ubiquitous in the world, adapted to multiple
environments and able to growth in themost extreme conditions.
Moreover, bacterial infection remains a leading cause of death in
both Western and developing world (WorldHealthOrganisation,
WHO)1. Understanding which bacteria proteins display prionic
properties could help to understand bacterial biology and
pathogenesis. Indeed, despite no genuine prion has been
characterized so far for prokaryotes, it is clear that at least
E. coli can generate infectious conformations of heterologous
fungal prions (Sabaté et al., 2009; Garrity et al., 2010; Espargaro
et al., 2012; Yuan et al., 2014). In an analogous manner, the
formation of amyloids was initially thought to be restricted to
eukaryotic cells, but after the first report demonstrating that the
curli fibers that emerge from the surfaces of E. coli cells had the
same physical properties as human amyloids (Chapman et al.,
2002), the number of discovered bacterial proteins displaying this
ability is steadily increasing (Otzen and Nielsen, 2008; Blanco
et al., 2012; Schwartz and Boles, 2013). Moreover, it has been
observed that bacterial amyloids can initiate the formation of
amyloid aggregates upon interaction with diverse host proteins
(Otzen and Nielsen, 2008; Hufnagel et al., 2013; Friedland, 2015;
Hill and Lukiw, 2015). With the aim to understand better the
potential relevance of bacterial PrDs, here we focus on study
the 2200 putative prion proteins predicted by PrionScan within
1http://www.who.int/mediacentre/factsheets/fs194/en/.
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the taxon domain bacteria, as derived from the study of 839
bacterial proteomes. Specifically, we analyze the functions and
structures associated to these proteins and discuss the possible
advantages that they could provide, ensuring their evolutionary
conservation.
MATERIAL AND METHODS
Sequence Dataset
Our database was comprised of Uniprot Knowledgebase
(UniProt, 2015) entries included both in Swissprot and TrEMBL
(update 2012_03) under the taxon domain bacteria in order to
track the prion like domains present in bacterial proteomes.
Discovering Putative Prion-like Domains
PrionScan, an algorithm developed by our group and described
previously (Espinosa Angarica et al., 2014), was used in order
to predict prion-like domains. Employing a cutoff of 50 bits,
we identified 2200 PrD (Table S1). Further analysis was made
a posteriori in order to identify common traits including
the Gene Ontology GO terms for the molecular functions,
biological processes, and cellular components and relevant
domains according to Pfam database. Pfam domains and GO
terms were manually annotated and counted in the 2200 positive
PrD containing bacterial proteins according to the Uniprot
annotations (UniProt, 2015). Due to the large amount of
individual Pfam domains, only those ones represented more than
five times were considered in the analysis. Then, we grouped the
domains by similarity in their cellular function or process. The
list of 18 selected pathogenic bacteria was manually annotated by
looking for evidences of a human pathogenic association at the
NCBI (Table S2). Then we calculated the enriched characteristics
of the PrD containing proteins associated to these bacteria.
The enrichment of the different GO terms and domains was
calculated as explained below. The enrichment values obtained
with the proteins detected in the subset of pathogenic bacteria
were compared with those obtained for the complete 2200 PrD
containing proteins dataset.
Statistics
The enrichment analysis was performed with GOStat (Beissbarth
and Speed, 2004) against the goa_uniprot database (UniProt,
2015). Out of 2200 initial proteins, 244 (11.09%) were annotated.
A p-value of 0.1 was set as a cut-off and a false discovery
rate (Benjamini) test was performed to obtain it. The initial
clustering was performed by classifying the obtained Gene
Ontologies according to their category: biological process,
cellular component or molecular functions. We calculated the
enrichment factors (EF) for every GO term to show how much
higher is the proportion of hits in relation to the background
sample (the total number of proteins). Accordingly, the EF is
the number of hits among PrDs (nl) divided by the number of
annotated proteins in our list (pl) and subsequently divided by
the ratio between the hits of that GO term in goa_annotation (nb)
and the total number of proteins (pb) in this specific GO term:
EF =
nl
pl
nb
pb
=
nlpb
nbpl
Only those GO terms with a log2-fold enrichment >0.5 were
considered to be significant for their subsequent analysis.
RESULTS
Identifying PrD in Bacteria Proteomes
We have analyzed 839 Bacteria proteomes containing a total
of 860337 proteins with PrionScan, from which we detected
2200 putative prion proteins scoring higher than 50 bits in the
algorithm scale (Espinosa Angarica et al., 2013) accounting for
a 0.3% of the complete protein dataset. Interestingly, in the
18 selected pathogenic bacteria (Table S2) proteins containing
PrDs are significantly more abundant (2.4%) and indeed they
constitute 40% of all the detected PrDs (891 PrDs). Moreover,
some specific pathogenic organisms appear to be specially
enriched in PrDs: Staphylococcus aureus (18%), Enterococcus
faecalis (10%), Enterococcus faecium (5%), or Staphylococcus
epidermidis (3%). These data show the diversity of putative PrDs
distribution and suggest certain associated functionality.
As an attempt to understand the biological purpose of these
PrDs we analyzed the Gene Ontology of the corresponding
proteins. Additionally, to facilitate its interpretation we
have grouped the enriched GO terms by similar cellular
function or process. After this classification, the biggest cluster
of GO terms collects Biological Processes involved in cell
morphogenesis, such as cell projection or cell wall dynamics.
This group contains 40 different terms, some of them with
fold enrichments above 200 (pilus assembly; Figure 1A). We
also found several enriched Biological Processes involved
in secretion, nutrient import, invasion and virulence; all of
them processes involved in interaction with the surrounding
environment. Interestingly, in invasion and virulence we
find processes associated to encapsulation, sporulation, and
interaction with other organisms. Between the Biological
Processes, the metabolic ones are particularly involved in
the assembly of macromolecules such as polysaccharides and
peptidoglycan (Figure 1B). The other three Biological Processes
clusters are nucleotide metabolism, stimulus to response and
localization, which are associated to cellular adaptation and the
formation of contacts between molecules. When we analyse
the Molecular Functions (Figure 2A), the GO terms enriched
can be grouped as: nucleic acid binding, metabolic processes,
drug binding, and transport. All of them activities associated
with the formation of functional interactions. Additionally,
the clusters of metabolic process and drug binding perform
functions related to cell wall such as peptidoglycan synthesis
or chitin production. Moreover, nucleic acid binding functions
could be associated to mechanisms of cellular adaptation. The
proteins in this cluster are strongly associated to two essential
functions such as translation initiation and DNA templated
transcription. Surprisingly, the GO terms of the Cell Component
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FIGURE 1 | Enrichment and clustering of bacteria PrD-containing proteins accordingly to their biological process GO terms. The enrichment analysis
was performed with GOStat against the goa_uniprot database. (A) Proteins with GO terms associated with cell morphogenesis. (B) Proteins with GO terms
associated to other biological processes.
do not include any inside part of the cell, just terms associated to
the external part: outer membrane, peptidoglycan based cell wall,
plasma membrane, cell wall, and proton transport in flagella
(Figure 2B; Namba, 2001). It is clear that many of the detected
proteins, and specifically those involved in nucleotide binding,
are located at the cytosol; however, because the large majority of
bacterial proteins are categorized as cytosolic, this results in a
poor enrichment factor for this compartment. Overall, the most
remarkable characteristics of the bacteria proteins containing
PrDs are their role in contact formation (e.g., macromolecular
assembly), their relationship with the cell periphery and their
involvement in nucleic acid mediated processes.
Structural Domains Linked to Bacteria PrD
Proteins
To learn more about the bacterial proteins that possess putative
PrDs we examined their constituent functional domains (Finn
et al., 2014; Figure 3). After clustering the Pfam domains we
obtained eight functional groups: nucleotide binding, cell wall
dynamics, invasion and virulence, protein-protein interaction,
iron transport, heat-shock, and unknown.
The most abundant group of Pfam families is the one
involved in nucleotide binding (1183 domains). There are
included domains associated to translation such as GTP-
binding elongation factors (GTP_EFTU), Rho termination
factors (Rho_RNA_bind and Rho_N) and translation initiation
factors (IF2 and IF2-N). Canonical nucleotide binding domains
are also be found such as the single stranded binding protein
(SSB), the single zinc ribbon domain (zinc_ribbon_2), the major
structural motif helix-turn-helix (HTHth-25), and the S1 RNA
binding domain. Finally, in this group we can also find an
ATP synthase domain, associated with Rho termination factors
(ATP-synt_ab), and the Ribonuclease B OB domain (Finn et al.,
2014).
The second most abundant group of Pfam families is,
once again, associated to cell wall dynamics (978 domains).
This group clusters domains involved in cell wall metabolism
(including biosynthesis and degradation) and proteins that bind
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FIGURE 2 | Enrichment and clustering of bacteria PrD-containing proteins accordingly to their GO terms. (A) Molecular function GO terms. (B) Cellular
component GO terms.
the wall to build functional structures. For example, the lysine
motif (Lysm) is involved in bacterial cell wall degradation
and may also have peptidoglycan binding function (Bateman
and Bycroft, 2000). The Glucosaminidase, Glycosyl transferase
family 2 (Glycos_transf_2) and Transpeptidase are three
domains associated with the biosynthesis of polysaccharides and
peptidoglycan (Finn et al., 2014). We also found 67 proteins
with a transglycosylase domain (Transgly) that catalyze the
polymerization of murein glycan chains as well as 12 proteins
with a SLH domain that is associated with the assembly of
(glyco)proteins that coat the bacteria surface. The PASTA domain
is involved in cell wall biosynthesis and can bind the beta-
lactam rings enclosed in antibiotics. The most abundant domain
from this group is the CHAP domain (245 proteins) with
an amidase activity implicated in cell wall metabolism. Other
domains also linked to cell wall are: the collagen domain
(connective structures), the NlpC/P60 family (Anantharaman
and Aravind, 2003; peptidases associated to lipoproteins), the
G5 domain (adhesion), the fibronectin type III (fn3, adhesion),
the cell wall binding motif 1 (CW_binding_1, a repeat similar
to some clostridia toxins) and the carbohydrate-binding module
(CBM_5_12, enriched in chitinases and associated to cellulose
scaffolding). Additionally, the unknown domain DUF1388 has
also been associated with surface lipoproteins.
The third group contains 130 proteins with domains
associated to secretion and invasion. Here we have several
domains associated to sporulation (SPOR) and spore
germination (GerA). The secretin domains are involved
in protein export via pore formation in a signal sequence-
dependent manner (Van der Meeren et al., 2013; Tosi et al.,
2014). The PDZ domains maintain together and organize
signaling complexes located throughout the cellular membranes.
Finally, the macrophage killing protein domain (ICmL) and the
Endotoxin_N are domains involved in the formation of pores at
the host cell membrane (Finn et al., 2014).
Between the PrD containing proteins we have also found three
different tetratricopeptide repeat domains (46 repetitions), which
scaffold protein-protein interactions and mediate the assembly
of multi-protein complexes. In addition, we also obtained 54
domains linked to iron binding and transport (Metallophos,
NEAT and FecR) and 58 proteins involved in heat shock response
(Anti-sigma factor N-terminus), both types of domains aimed to
interact with or to transduce signals coming from the cell external
microenvironment.
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FIGURE 3 | Number of different Pfam domains found in PrD-containing
proteins. The domains are indicated by their Pfam ID. This plot only shows
the domains with >5 repetitions in the dataset.
Overall, the functional families of the PrD containing
proteins (Figure 3) match very well with their GO classifications
(Figures 1, 2) and confirm that these proteins are associated to
the external part of the cell (e.g., cell wall) and interactions with
other molecules (e.g., nucleotide binding).
Structure Composition of Bacteria PrD
Containing Proteins
As expected, the detected PrDs are located inside low complexity
regions (e.g., disordered, coiled coil, etc; Figures 4, 5). Moreover,
these regions are abundant in the PrD containing proteins
and connect different domains (Figure 4) and elements with
secondary structure (Figure 5).
From 2200 PrD containing proteins, 1514 have at least one
defined Pfam domain (69%). Additionally, 612 of these sequences
(40%) have more than one structural domain (Ekman et al.,
2005). When we focus on the PrD containing proteins from
pathogenic bacteria (Figure 6), we observe that they have a
lower number of designated Pfam domains (just 301 proteins)
suggesting they could be less structured proteins or, more likely,
carry still unknown domains and functions. Despite this, the
proteins from pathogenic bacteria with reported Pfam domains
tend to contain more than one structural domain family (Table
S2). The percentage of proteins with multiple domains appears to
be higher in these proteomes (60%) than in the complete protein
dataset (Ekman et al., 2005).
When the proteins have multiple structural domains, the PrD
regions can be located either close to an end or between structures
(Figure 4A). Interestingly, the amino acid composition of
the PrD regions is similar between proteins sharing similar
domain arrangement but different between proteins with distinct
domains composition (Figure 4B). In agreement with the data
reported for yeast prions, we observe that the detected regions
are abundant in N (30%), Q (21%), S (11%), and G (11%).
The domain combinations tend to be functionally associated.
For example, we found 233 protein sequences containing two
GTP-binding elongation factor domains and two translation
initiation factor domains that are related with nucleotide
binding and translation (Figure 4). During protein synthesis the
initiation factors (IF2) form a ternary complex with GTP and
the initiator Met-tRNA (Wienk et al., 2005). This complex binds
the ribosome to interact with the AUG-codon of the starting
methionine, once the codon is found IF2 has to hydrolyze its GTP
to be released (Figures 5A,B).
P60 domain is a cell-wall-associated peptidase domain
essential for adherence and invasion in some Listeria species.
In agreement with previous studies (Ponting et al., 1999;
Anantharaman and Aravind, 2003), we observed the P60 domain
associated with SH3 and LysM domains (Figures 4, 5C,D). It
has been hypothesized that this team facilitates the domains
interaction with peptides, carbohydrates and lipids from the
bacterial cell wall and thus their functionality (Ponting et al.,
1999; Anantharaman and Aravind, 2003).
Rho factor proteins tend to be accompanied with an RNA-
binding domain and an ATP-hydrolysis domain (Figure 4). The
Rho termination factor disengages newly transcribed RNA from
its DNA template. Rho catalyzes the 3′ endpoint formation
and the release of mRNA molecules from DNA templates
(Skordalakes and Berger, 2003). The hydrolysis of ATP provides
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FIGURE 4 | PrD-containing proteins also contain multiple domains. (A) Diagrams showing a consensus distribution and size of the most common domain
combinations as collected in Pfam. The gray spaces indicate low complexity regions (coiled coil, disorder, etc). The domains are indicated by their Pfam ID. (B) PrD
sequence conservation measured in bits. The symbol height reflects the relative frequency of the corresponding amino acid at that position. Color code: N in black; G
in red; G, S, and Y in green; the other residues in purple (Crooks et al., 2004).
the energy required to get the RNA-DNA region and break the
hybrid structure.
Another example of functional domain combination that
contains PrDs are the penicillin-binding proteins. They are
bifunctional proteins involved in the final stages of the
peptidoglycan synthesis (Figures 4, 5E). At the N-terminus
there is a transglycosylase domain involved in the formation
of linear glycan strands. And at the C-terminus there is a
transpeptidase domain involved in the cross-linking of peptide
subunits and drug binding, which is also responsible of the
penicillin-sensitivity (Macheboeuf et al., 2005; Sauvage et al.,
2008; Contreras-Martel et al., 2011).
NLPC/P60 and Glucosaminidase are two cell wall
endopeptidase domains, which emerged together and that
we have found accompanied with a PrD (Figure 4). These two
domains are commonly employed to cleave the septa connecting
the daughter cells during cell separation (Anantharaman and
Aravind, 2003; Ruggiero et al., 2010).
The secretins are another example of domain combination
found in our set of PrD bacteria containing proteins (Figures 4,
5F). Particularly it is the most abundant combination of two
domains (67 times) found in the PrD containing proteins.
The secretin domains detected take part in protein secretion
systems type II and III. They build multimeric pores to transport
macromolecules either to the periplasm or to inject them into
eukaryotic cells (Tosi et al., 2014). In general, secretin proteins
consist of two domains: an N-terminal periplasmic domain
responsible of the pore formation and a C-terminal domain
responsible of the attachment to the outer membrane (Van der
Meeren et al., 2013; Tosi et al., 2014). Interestingly, the PrD
domain detected is located between these two secretin domains
(Figure 4).
DISCUSSION
Bacterial PrDs are Associated to Cellular
Adaptability
We observed that a significant fraction of the bacteria PrD
containing proteins are located at the cell periphery and
are involved in cell wall metabolism, especially peptidoglycan
biogenesis. Peptidoglycan is the major component of bacterial
cell walls; it is essential for growth, cell division, andmaintenance
of the cellular shape, enabling the bacteria to resist intracellular
pressures of several atmospheres. In some particular cases,
the proteins present in the peptidoglycan can be anchored to
the biofilm amyloid network and, more interesting, assist its
assembly. This is the case of the TapA protein from B. subtilis,
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FIGURE 5 | Structure of the domains located in the PrD-containing proteins. Representative structures of the domains and domain combinations enclosed in
the PrD-containing proteins. The domains are indicated by their Pfam ID. (A) Example of quaternary complex where a multi-domain structure, composed by IF-2,
IF2_N, and GTP_EFTU domains, interact with a tRNA. The image shows partial information from the PDB structure 1MJ1. Fitting the ternary complex of
EF-TU/tRNA/GTP and ribosomal proteins into a 13 angstroms cryo-EM map of the E. coli’s 70S ribosome. (B) Example of IF-2 domain structure and the different
states of the disordered region located in front of it. PDB structure 1z9b. Solution NMR structure of the C1-subdomain of Bacillus stearothermophilus translation
initiation factor IF2 (fragment 515–635). (C) Example of multi-domain structure composed by a NlpC-P60 and a Lysm domains. PDB structure 4XCM. Crystal
structure of the putative NlpC/P60 D,L endopeptidase from Thermus thermophilus. (D) Example of SH3_3 domain structure and the different states of the disordered
region located after it. PDB structure 2KRS. Solution NMR structure of SH3 domain from CPF_0587 (fragment 415–479) from Clostridium perfringens. (E) Example of
multi-domain structure composed by a transglycosylase and a transpeptidase domain. PDB structure 3ZG7 Crystal Structure of Penicillin-Binding Protein 4 from
Listeria monocytogenes in the apo form. (F) Structure showing a homodimer constituted by Secretin_N domains. PDB structure 4E9J. Crystal structure of the
N-terminal domain of the secretin XcpQ from Pseudomonas aeruginosa. Notice that at the multi-domain structures (B,D) the low complexity regions are abundant.
which is present in the peptidoglycan, where it functions as an
anchor point for TasA fibers. (Sauvage et al., 2008; Romero et al.,
2011; Friedland, 2015). The formation of biofilms is a powerful
strategy that protects a bacterial community from chemicals and
antibiotics and facilitates the attachment to different surfaces
even host cells. Interestingly, S. aureus, a biofilm forming
pathogen, is the bacteria specie with the highest content in PrDs.
In this organism we found PrD-containing proteins linked to
cell wall, proteins involved in secretion and proteins associated
to virulence. These data point to a possible relationship between
the identified proteins and the biofilm formation. In fact, the S.
aureus PrD-containing protein staphylococcal secretory antigen
ssaA2 (Uniprot code Q2G2J2) is able to form amyloid fibrils in
vitro (S.V. unpublished results). Thus, a more exhaustive analysis
of these proteins might confirm their association to biofilms
formation and their possible role as a drug targets.
The other processes enriched in the PrD containing proteins
can also provide versatility and adaptability to different
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FIGURE 6 | Clustering of GO terms and Pfam domains associated to PrD-containing proteins in pathogen bacteria. (A) Cellular component GO terms. (B)
Biological Process GO terms. (C) Molecular Function GO terms. (D) Pfam domains associated.
environments. For instance, the proteins involved in stimulus
response and invasion and in virulence have a clear role in
supporting the bacteria development under variable conditions.
From inside the cell the nucleotide binding proteins can
be involved in functions that support cell adjustment such
as transcription and translation (i.e., change the expression
levels) or DNA repair that can enhance cell survival in stress
conditions. Interestingly, most of the novel prion-like proteins
discovered recently in humans play a role in RNA/DNA
binding (King et al., 2012). In bacteria, we also found proteins
involved in cellular localization that can rearrange different
compounds adapting the cell to new requirements. Overall,
as previously proposed for yeast prions, bacterial prions
might serve as bet-hedging devices for diversifying microbial
phenotypes.
Bacterial PrDs are Associated to
Functional and Interacting Proteins
The 69% of PrDs containing proteins have defined Pfam domains
and 40% of them carry multiple domains. Since domains come
together to increase proteins functionality (Anantharaman and
Aravind, 2003; Alberti et al., 2009), our data suggest that
the proteins with PrDs tend to be functional. Moreover, in
pathogenic bacteria PrD are associated to higher percentage
of proteins with multiple domains, more than the average of
the proteomes from this taxon (Ekman et al., 2005). This data
suggests that, in pathogenic bacteria, PrD containing proteins
might have a versatile character.
The detected PrDs are located in proteins rich in low
complexity regions. These regions are important to provide
the structural flexibility required to form interactions
between proteins. This flexibility also allows the formation
of reversible interactions, which are essential to build dynamic
macromolecular assemblies. In fact, the GO terms associated
to the PrDs detected by PrionScan comprise functions and
processes linked to interaction and assembly. Many of these GO
terms involve binding proteins, nucleotides or other cellular
compounds. Human RNA/DNA binding proteins use their PRDs
to attain functional macromolecular assemblies that regulate
transcription and translation. In many cases these functions are
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exerted in the so called ribonucleoprotein granules (Malinovska
et al., 2013). Many of the proteins containing DNA/RNA
binding domains identified in the present also work by forming
large complexes and indeed are implied in ribonucleoprotein
complex biogenesis and assembly suggesting that this property
can be conserved across species. In addition, the association
to cell wall dynamics suggests that certain proteins can be
implied in the assembly and disassembly of peptidoglycans and
polysaccharides. Overall, our data supports that, as previously
suggested for eukaryotic PrDs, bacteria PrDs could play an
important role in the arrangement of macromolecular structures
(Malinovska et al., 2013).
Prions in other Proteomes
Saccharomyces cerevisiae is the organism from which more
information about its prion proteins has been so far collected
(Alberti et al., 2009; Malinovska et al., 2013). These works
showed for the first time that proteins could be employed
for amazing functions such as epigenetic elements essential to
adapt the cellular metabolism and increase the cell survival in
front of environmental changes (Alberti et al., 2009; Newby and
Lindquist, 2013). In S. cerevisiae the prion proteins are associated
to functions that involve the formation of contacts such as
RNA-binding, membrane-interacting, DNA binding and protein
interaction domains (Malinovska et al., 2013). These proteins
are located at the cytoskeleton, nucleus, ribonucleoprotein
complexes, and chromatin. Comparing S. cerevisiae with other
eukaryotic proteomes shows PrD-containing proteins with
similar function and location. For example, in human and
fruit fly these proteins are also involved in transcription,
chromatin remodeling, ribonucleoprotein complex formation,
and cytoskeleton (Malinovska et al., 2013). In animals, PrDs tend
to be involved in the regulation of central biological processes
and organism development, which in vertebrates includes
the development of the neural crest. Hence, many human
PrD are found in RNA-binding proteins, which deregulation
has previously been associated with several neurodegenerative
diseases (King et al., 2012).
Eukaryote PrD-containing proteins show less functional
diversity than bacteria. In fact, here we have collected all the
enriched eukaryote functions (i.e., transcription, RNA binding,
and DNA binding) in just one cluster (nucleotide binding).
Despite this difference, it appears that, independently of the
considered taxon, PrD-containing proteins appear to be involved
in a similar regulatory purpose: adapting the cell to a variable
environment. This purpose is basically achieved through the
control of the expression in eukaryotes, but in prokaryotes
this is also reached by interacting with the environment,
since microorganisms face the constant challenge of fluctuating
conditions in their natural environments. These strategies may
have facilitated the invasion of new environments (e.g., water, air)
and the coexistence or exploitation of diverse life forms (e.g., host
cells).
Bacteria PrDs and Human Diseases
Our life is closely linked to bacteria, either through a parasitic
or symbiotic relationship. On one hand, human microbiota is
required to assist many processes and ensure a healthy body.
On the other hand, many common pathogenic bacteria are
acquiring antibiotic resistance in all regions of the world (e.g.,
urinary tract infections, pneumonia, bloodstream infections;
WorldHealthOrganisation, WHO). These bacteria cause many
hospital-acquired infections, such as the methicillin-resistant S.
aureus, with an associated high mortality rate (Contreras-Martel
et al., 2011; WorldHealthOrganisation, WHO).
To the already intricate scenario where bacteria and host
interact, the risk of their amyloid proteins concurring and
altering their conformational states adds an extra level of
complexity (Otzen and Nielsen, 2008). Additionally, the long
periods that bacteria stay in the body, due to chronic infection
or microbiota coexistence, enhances the chances of this event.
In fact, recent studies have demonstrated that bacterial amyloids
can initiate the formation of amyloid aggregates upon interaction
with host proteins (Otzen and Nielsen, 2008; Zhou et al.,
2012; Hufnagel et al., 2013; Hill and Lukiw, 2015). Moreover,
it has been reported that the injection of bacteria amyloids
in mice causes the development of amyloidosis (Lundmark
et al., 2005). Overall, these data reminds the conformational
template process associated to prion transmission and suggest
that bacterial infection could be linked to neurodegenerative
diseases (Friedland, 2015).
General Conclusions
Despite PrD-containing proteins seem to be ubiquitous
(Espinosa Angarica et al., 2013; Malinovska et al., 2013) they play
distinct functional roles in different species. In this background,
the mechanisms underlying host-bacteria relationship are just
starting to be elucidated and, as a result, also the interplay
between their amyloid proteins (Zhou et al., 2012; Schwartz
and Boles, 2013; Seviour et al., 2015). The studies on bacteria
amyloids are showing us that amyloid aggregates can be
exploited to execute wide range of amazing functions (Blanco
et al., 2012; DePas and Chapman, 2012; Gsponer and Babu,
2012; Zhou et al., 2012; Schwartz and Boles, 2013; Evans et al.,
2015; Seviour et al., 2015; Taylor and Matthews, 2015). Because
the formation of amyloids comes at expenses of the formation
of transient toxic species cells tightly control the assembly of
these macromolecular structures and how they can interact with
proteins from other species (Zhou et al., 2012; Schwartz and
Boles, 2013; Evans et al., 2015; Taylor and Matthews, 2015). Most
of the bacterial amyloids described so far play a structural role
and work extracellularly. Indeed, some of the PrD containing
proteins with potential amyloidogenic properties could be linked
to biofilms, structures that favor chronic human infections and,
consequently, increase the chances of a potential bacterial prion
to alter the conformation of host proteins. However, despite
their in vitro amyloid potential and in vivo prionic behavior
should be validated, the data in the present work suggest that,
as it happens in yeast and humans, also in bacteria amyloid-like
assemblies might play a regulatory role, since some of the
detected candidates are linked to fundamental cellular functions
such as transcription, translation or DNA repair. Intriguingly,
linking the fact that we found at the same time association with
extracellular environment and nucleic acid binding function,
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it has been reported recently that extracellular DNA is bound
tightly by bacterial amyloid fibrils during biofilm formation
and that amyloid/DNA composites are immune stimulators
when injected into mice, leading to autoimmunity (Gallo et al.,
2015; Spaulding et al., 2015). Overall it becomes clear that a
more exhaustive analysis of the putative bacterial prion proteins
identified here is required in order to attain a better understand
of their functional role and their relationship with human
diseases. This data could help to identify new drug targets and
develop new therapies.
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